Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Moderna, Inc. $MRNA Shares Newly Bought by Americana Partners LLC
Cancer Vaccine Win Could Be A Turning Point For Moderna Stock (MRNA)
VIRGINIA RETIREMENT SYSTEMS ET Al Buys 2,400 Shares of Moderna, Inc. $MRNA - Daily Political
Biotech Stocks Worth Watching - October 31st - Markets Daily
How Investors Are Reacting To Moderna Stock Phase 3 Melanoma Vaccine Data
Moderna, Inc. $MRNA Stock: Oppenheimer & Co. Inc. Raises Position
7,007 Moderna, Inc. $MRNA Shares Acquired by Oppenheimer & Co. Inc. - Daily Political
Top Biotech Stocks To Follow Today - October 29th - Stock Observer
Best Healthcare Stocks To Research - October 29th - Stock Observer
Biotech Stocks To Keep An Eye On - October 30th
Regeneron Surges 12% as Sanofi Dupixent Windfall and Eylea HD Power Earnings Beat; Moderna Slides 2%, Merck Edges Higher, Pfizer Ticks Up
Healthcare Stocks To Follow Now - October 30th - Stock Observer
Moderna (MRNA) Climbed, So What Is Driving Attention Now?
North Dakota State Investment Board Sells 27,663 Shares of Moderna, Inc. $MRNA
Moderna, Inc. $MRNA Stock: China Universal Asset Management Co. Ltd. Increases Stake
Moderna, Inc. $MRNA Stock Holdings Boosted by D.A. Davidson & CO.
Moderna (MRNA) Set to Post Quarterly Earnings on Friday
Moderna (NASDAQ:MRNA) Shares Up 4% - Here's What Happened
Podcast: ESMO26: Major readouts from the 2026 congress
Bird Flu On Mink Farms: What It Means For Human Health
iShares Russell Mid-Cap Value (IWS) Sells Phillips 66 and HPE on Oct. 27
Motley Fool Asset Management LLC Acquires 23,326 Shares of Moderna, Inc. $MRNA
Here's Why Moderna's CEO Isn't Fazed by Its Cancer-Vaccine Selloff | World News
Merck News | Markets Insider
Breakthrough cancer vaccine catches Wall Street's attention
Moderna (NASDAQ:MRNA) Shares Up 3% - What's Next?
13,296 Shares in Moderna, Inc. $MRNA Bought by Great Lakes Retirement Inc.
Merck & Co., Inc. $MRK Stock Purchased by DMC Group LLC - Markets Daily
Generali Asset Management SPA SGR Purchases 17,772 Shares of Merck & Co., Inc. $MRK - Stock Observer
Influenza A Market Size in the 7MM is projected to reach ~USD 10,000 million by 2036, growing at a CAGR of 7.9% during 2026-2036 | DelveInsight | ABNewswire
Melanoma vaccine trial reveals promising results
Moderna Stock Plunges. William Blair Issues Fresh Warning After Massive Rally
ESMO26: Other skin cancer advances beyond groundbreaking cancer vaccine
Biotech Stocks To Watch Now - October 27th - Markets Daily
Moderna (NASDAQ:MRNA) Stock Jumps 4.6% - Here's Why - Daily Political
MRK vs. MRNA Stocks: Who Wins More From the Cancer Vaccine?
Moderna shares slip as William Blair cuts rating on valuation after rally
Moderna, Inc. (NASDAQ:MRNA) Stock Has Average Price Target of $101.45 - Markets Daily
Billionaire Moderna Founder Is Betting on More Improbable Ideas
Here Are Tuesday's Top Wall Street Analyst Research Calls: Broadcom, Conoco Phillips, HubSpot, MercadoLibre, Moderna, Occidental Petroleum, PNC Financial, Trimble, and More
Robeco Institutional Asset Management B.V. Makes New Investment in Moderna, Inc. $MRNA
FY2028 EPS Estimate for Moderna Cut by Analyst
Moderna (NASDAQ:MRNA) Stock Dropped to Market Perform by William Blair
Moderna (MRNA) Stock Looks Above Fair Value After Fresh Pipeline News
Robeco Institutional Asset Management B.V. Purchases 7,539 Shares of Moderna, Inc. $MRNA
FY2028 EPS Forecast for Moderna Lowered by Analyst - Daily Political
FY2030 EPS Estimate for Moderna Lowered by Analyst - Zolmax
Moderna (MRNA) Gets Phase 3 Melanoma Vaccine Validation At ESMO And NEJM
A Skin Cancer Vaccine May Be on the Way as Moderna and Merck Release Promising Results
Best Biotech Stocks Worth Watching - October 26th - Markets Daily
ESMO '26: A cancer vaccine debate, Roche's KRAS progress and Amgen's 'unprecedented' data
The excitement around Moderna's cancer vaccine is cooling. Here's why. | Morningstar
Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady
Best Healthcare Stocks To Watch Today - October 26th - Stock Observer
EULAV Asset Management Acquires 9,727 Shares of Moderna, Inc. $MRNA
Moderna, Inc. $MRNA Shares Sold by IFP Advisors Inc
Brookline Capital Markets Estimates Moderna FY2030 Earnings
Merck & Co., Inc. $MRK Holdings Lessened by Sigma Planning Corp - Daily Political
Promising Healthcare Stocks To Keep An Eye On - October 25th - Markets Daily
Wells Fargo, Cisco, Intuit Among 6 More Companies Objecting to Tokenized Stocks
Moderna (MRNA) Stock May Be Fully Priced As Melanoma Vaccine Data Leaks
Merck & Co., Inc. $MRK Stake Boosted by Norris Perne & French LLP MI - Markets Daily
Merck & Co., Inc. $MRK Position Trimmed by Middleton & Co. Inc. MA - Markets Daily
Merck & Co., Inc. $MRK Stock Bought by Norris Perne & French LLP MI - Stock Observer
Moderna Melanoma Therapy Cuts Recurrence Risk 42% in Phase 3 Trial
Biotech stocks rally on drug innovation and M&A
Merck & Co., Inc. $MRK Holdings Decreased by Sterling Capital Management LLC - Stock Observer
Moderna investors should brace for more whiplash | World News
5,000 Shares of Moderna, Inc. $MRNA Bought by Credit Capital Investments LLC
Breakthrough Melanoma Vaccine from Merck and Moderna Reduces Death Risk by 42%, ETPharma
Moderna (NASDAQ:MRNA) Shares Down 1.2% - Time to Sell?
Moderna stock extends losses as investors digest melanoma vaccine trial data
Think annuities are a rip-off? Now might be the perfect time to reconsider. | Morningstar
Health Matters: Vaccine shows positive signs for melanoma patients
Oncologists Cheer Melanoma Data That Tanked Moderna's Shares (1)
Doctors call Moderna, Merck cancer vaccine data a major advancement - despite Wall Street reaction
William Blair analyst on Moderna's stock plunge following cancer vaccine data leaks
Moderna trims losses as investors digest melanoma vaccine trial data
Interpath-100: data leak, stock drop, spirited defense by ESMO president
Personalized mRNA Vaccine Cuts Melanoma Death Or Recurrence Risk 42%
Moderna stock extends decline after leaked data on melanoma vaccine trial
Moderna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer Slip
Promising Healthcare Stocks To Consider - October 23rd - Stock Observer
Did You Lose Money on Moderna, Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 23.07% Share Price Decline | Morningstar
Moderna (MRNA) Stock Drops 17% Despite Melanoma Trial Success
Stocks making the biggest moves premarket: AT&T, SpaceX, Moderna, Deckers, Bloom Energy and more
Capital Group Global Growth (CGGO) Buys $121.1 Million More Moderna on Oct. 21
Moderna Stock Selloff: Why positive cancer vaccine results failed to lift shares
Dow Jones Top Company Headlines at 1 AM ET: SK Hynix Shelves Memory-Chip Unit U.S. IPO Plan on Market Jitters | Moderna's ... | Morningstar
After Moderna's 672% Climb, The Story Has Changed
Moderna, Inc. (NASDAQ:MRNA) Stock Has Consensus Target Price of $101.45 According to Analysts - Stock Observer
Dow Jones Top Company Headlines at 11 PM ET: SK Hynix Shelves Memory-Chip Unit U.S. IPO Plan on Market Jitters | Moderna's ... | Morningstar
Moderna's $24 Billion Loss: Analysts Attribute Drop to 'Sell-the-News' After Cancer Vaccine Results, ETPharma
Moderna stock's 17% slump was a 'sell the news' event, analyst says
Personalized mRNA vaccine lowers melanoma risk
Oncologists cheer melanoma data that tanked Moderna's shares | News & Features | ArcaMax Publishing
Moderna News
Boeing Stock Forecast 2026–2030: Can a Record $745 Billion Backlog Reverse BA’s 11% Earnings Sell-Off?
Moderna Shares Fall 18% After Cancer Vaccine Data Leak Triggers Sell-Off
CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?
Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks
Moderna Stock Rebounds 4.81% as Cancer Vaccine Focus Builds Ahead of Nasdaq-100 Return
Latest news
Show more
Amazon Q3 Earnings: AWS Growth Hits 39.3% as AI Spending Weighs on Cash Flow
Intel Stock Crashes 18% as Weak Q4 Forecast Overshadows 78% AI Server Growth
Bitcoin Price Falls Below $80,000 as Binance Reports $6.3 Billion Security Incident
Alphabet Stock Falls 12% as Search Slowdown and AI Spending Unsettle Investors
Apple Earnings Preview: Can iPhone Growth and the Duo Foldable Justify AAPL’s Valuation?
